Orphenadrine and Methocarbamol for LBP

• Status: Completed
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Low back pain is a common cause of visit to emergency department. It is not clear if skeletal muscle relaxants are of benefit for patients with acute low back pain. This is a randomized study to determine if skeletal muscle relaxants, when combined with naproxen, improve outcomes more than naproxen alone

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Montefiore Medical Center
• Treatments: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cholinergic Antagonists; Methocarbamol; Naproxen; Orphenadrine

Criteria

Inclusion Criteria:

• LBP duration <= 2 weeks

• No trauma to low back within previous month

• No radicular symptoms

• No history of low back pain or history of only infrequent episodes

Exclusion Criteria:

• Medication allergies or contra-indications

• Not available for follow-up

• Chronic pain syndrome